z-logo
open-access-imgOpen Access
A rare case of accelerated gingival overgrowth with high dose amlodipine therapy
Author(s) -
B M Rakesh,
Sahithi Sharma,
K H Chandana
Publication year - 2021
Publication title -
journal of pharmacovigilance and drug research
Language(s) - English
Resource type - Journals
ISSN - 2582-7235
DOI - 10.53411/jpadr.2021.2.1.8
Subject(s) - amlodipine , nifedipine , medicine , calcium channel , gingivectomy , calcium channel blocker , drug , gingival enlargement , side effect (computer science) , hyperplasia , calcium , dermatology , dentistry , pharmacology , computer science , programming language , blood pressure
Gingival overgrowth represents an over-exuberant response to a variety of local and systemic conditions. Certain anticonvulsants, immunosuppressive drugs, and a number of calcium channel blockers have been shown to produce similar gingival overgrowth in susceptible patients. Case report: We report a case of accelerated drug-induced gingival overgrowth in a 60-year-old hypertensive patient taking amlodipine at a dose of 10 mg. Conclusions: Among the calcium channel blockers, nifedipine is most frequently associated with gingival overgrowth.  Whereas, there is limited evidence of amlodipine-induced gingival hyperplasia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom